Burden of severe illness associated with laboratory confirmed influenza in adults aged 50-64 years: A rapid review.

Abstract

BackgroundWhile the high burden of illness caused by seasonal influenza in children and the elderly is well recognize, less is known about the burden in adults 50–64 years of age. The lack of data for this age group is a key challenge in evaluating the cost‐effectiveness of immunization programs. We aimed to assess influenza‐associated hospitalization and mortality rates and case fatality rates for hospitalized cases among adults aged 50–64 years.MethodsThis rapid review was conducted according to the PRISMA; we searched MEDLINE, EMBASE, Cochrane, Web of Science, and grey literature for articles and reports published since 2010. Studies reporting rates of hospitalization and/or mortality associated with laboratory‐confirmed influenza among adults 50–64 or 45–64 years of age for the 2010–11 through 2019–20 seasons were included.ResultsTwenty studies from 13 countries were reviewed. Reported rates of hospitalization associated with laboratory‐confirmed influenza were 5.7 to 112.8 per 100,000. Rates tended to be higher in the 2015–2019 compared with the 2010–2014 seasons and were higher in studies reporting data from high‐income versus low and middle‐income countries. Mortality rates were reported in only one study, with rates ranging from 0.8 to 3.5 per 100,000 in four different seasons. The case fatality rate among those hospitalized with influenza, as reported by population‐based studies, ranged from 1.3% to 5.6%.ConclusionsSeasonal influenza imposes a significant burden of morbidity on adults 50–64 years of age but with high heterogeneity across seasons and geographic regions. Ongoing surveillance is required to improve estimates of burden to better inform influenza vaccination and other public health policies.